Vinva Investment Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,015
Closed -$205K 472
2025
Q3
$205K Sell
4,015
-6,900
-63% -$198K ﹤0.01% 419
2025
Q2
$458K Buy
+10,915
New +$316K 0.01% 359
2025
Q1
Sell
-8,929
Closed -$575K 437
2024
Q4
$575K Sell
8,929
-6,337
-42% -$240K 0.02% 340
2024
Q3
$744K Buy
+15,266
New +$429K 0.03% 335

Other funds holding VCYT

Vinva Investment Management's VCYT Position: Q4 2025 in Review

Vinva Investment Management sold out of Veracyte (VCYT) in Q4 2025, closing a stake of 4,015 shares — an estimated $205K sold.

Vinva Investment Management first reported a position in VCYT in Q3 2024 and held it in 4 quarters. The position peaked at $744K in Q3 2024. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

  • Vinva Investment Management reported no remaining Veracyte position as of Q4 2025 after selling out during the quarter.
  • Vinva Investment Management sold 4,015 Veracyte shares in Q4 2025, an estimated $205K.
  • Vinva Investment Management first reported a position in Veracyte in Q3 2024 and held it in 4 quarters.
  • Vinva Investment Management's Veracyte position peaked at $744K in Q3 2024.
  • 329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on Vinva Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.